Post-Market Surveillance for Cosmetics in India: What CDSCO Expects After Launch

Getting a Cosmetic product registered and onto shelves in India is only half the job. Once a product is in the market, the Cosmetics Rules, 2020 place ongoing duties on manufacturers and Importers to keep watching it. This is called post-market surveillance, and it is becoming one of the areas where CDSCO (the Central Drugs Standard Control Organisation) is paying closer attention.

This article explains, in plain terms, what post-market surveillance means under the 2020 Rules, who is responsible for it, and what companies should have in place.

Why Post-Market Surveillance Exists

A product can pass every pre-market check and still causes a problem once millions of people start using it. Skin reactions, contamination during manufacturing, or a batch that does not meet quality standards can all surface only after launch. Post-market surveillance is the system that is supposed to catch these problems and act on them.

Under the Cosmetics Rules, 2020, this is not a voluntary best practice — it is a regulatory expectation built into the framework of licensing, inspection, and reporting.

The Two Authorities Involved

India’s Cosmetics regulation runs on two parallel tracks, and it helps to know which one applies to a given product:

• Central track: CDSCO, through the Central Licensing Authority (CLA), handles Import registration. If your product is imported into India, CDSCO is your primary point of contact for import-related compliance and reporting.
• State track: State Licensing Authorities (SLAs) handle manufacturing licenses issued to factories located within their state. If you manufacture in India, your local SLA is responsible for licensing and inspecting your facility.

Both tracks feed into the same overall post-market surveillance system, so companies that both manufacture locally and import need to track obligations on both fronts.

Reporting Adverse Actions Taken Anywhere in the World

One of the clearest surveillance duties under the 2020 Rules concerns global regulatory action. If a regulatory authority anywhere in the world takes action against your product — for example, a market withdrawal, a sales restriction, or cancellation of an approval — you are expected to report this to CDSCO without delay.
In practical terms, this means:

Dispatch and marketing of the product in India should be paused while the matter is resolved.

The company should not wait for CDSCO to ask; the obligation is to inform proactively.

This applies even if the regulatory action happened in a country far from India, if it concerns the same product or formulation.

For companies selling the same cosmetic brand across many countries, this means building an internal process to flag global regulatory actions and route them quickly to the India compliance team.

Routine Inspections of Manufacturing Sites

Cosmetic manufacturing facilities licensed under the 2020 Rules are inspected periodically to check that the site continues to meet licensing conditions and the requirements of the Rules. Two things are worth understanding here:

1. Minimum frequency: Inspections happen at least once every three years.
2. Risk-based approach: Inspections can also happen more often, based on risk. A site with a history of complaints, quality issues, or a higher-risk product category may be inspected more frequently than the three-year minimum.

This means “we were inspected once, we’re fine for three years” is not a safe assumption. If your risk profile changes — for instance, after a product recall or a spike in consumer complaints — you should expect closer attention.

What This Means for Your Compliance Program

Based on these requirements, a reasonably mature post-market surveillance program for an Indian cosmetics business should include:

• A complaint-handling process that captures consumer complaints, categorizes them byseverity, and escalates safety-related ones quickly.
• A global regulatory-watch function, especially for companies that sell the same formulation in multiple countries, so that action taken abroad is not missed or reported late.
• Inspection readiness, meaning your manufacturing site’s documentation, batch records, and quality systems are always kept current, not tidied up only before a scheduled visit.

A clear internal owner for post-market compliance, since this responsibility often falls through the cracks between regulatory affairs, quality, and marketing teams.

A Word on Getting the Interpretation Right

Post-market surveillance provisions are sometimes confused with pre-market registration requirements, or with the separate obligations that apply to Drugs under India’s Pharmacovigilance system. Cosmetics are regulated distinctly, and the surveillance duties described above come specifically from the Cosmetics Rules, 2020 and the associated licensing conditions — not from Drug safety reporting frameworks. Companies operating across both Drug and Cosmetic portfolios should be careful not to apply Drug-style Pharmacovigilance timelines or formats where the cosmetics framework does not require them.

Closing Thought

Post-market surveillance is not a one-time filing — it is a standing responsibility that runs for as long as your product is sold in India. Companies that treat it as an ongoing operational function, rather than a compliance checkbox, are in a far stronger position when an inspector visits or when a global recall notice needs to be reported.

In the next article in this series, we look at how cosmetic claims must be substantiated under the 2020 Rules, and what kind of evidence CDSCO expects to see behind statements like “clinically proven” or “dermatologist tested.”

Key Takeaways

• Post-market surveillance is an ongoing compliance responsibility after product launch.
• Maintain systems for consumer complaints, adverse reactions, and product quality concerns.
• Investigate safety or quality issues and implement appropriate corrective actions.
• CDSCO/CLA oversees Imported Cosmetics, while SLAs regulate domestic manufacturing.
• Keep licences, batch records, quality documents, and other records inspection-ready.
• Monitor significant global regulatory actions affecting products marketed in India.
• Assign clear internal responsibility for post-market compliance activities.
• Maintain documented procedures to support continued regulatory compliance and consumer safety.